INTERLINE INTERSTELLAR Trademark
Trademark Overview
On Tuesday, May 30, 2023, a trademark application was filed for INTERLINE INTERSTELLAR with the United States Patent and Trademark Office. The USPTO has given the INTERLINE INTERSTELLAR trademark a serial number of 98018777. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 6, 2025. This trademark is owned by INTERLINE THERAPEUTICS, INC.. The INTERLINE INTERSTELLAR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceuticals research and development; Scientific and medical research and information services in the field of pharmaceutical development; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Research and development of therapeutic drugs for the prevention or treatment of human diseases; Scientific research in the field of drug discovery and development for others; Biomedical research services; Scientific research; Preclinical development of therapeutic product
General Information
| Serial Number | 98018777 |
| Word Mark | INTERLINE INTERSTELLAR |
| Filing Date | Tuesday, May 30, 2023 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, January 6, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 2, 2024 |
Trademark Statements
| Goods and Services | Pharmaceuticals research and development; Scientific and medical research and information services in the field of pharmaceutical development; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Research and development of therapeutic drugs for the prevention or treatment of human diseases; Scientific research in the field of drug discovery and development for others; Biomedical research services; Scientific research; Preclinical development of therapeutic product |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 29, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | INTERLINE THERAPEUTICS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Brisbane, CA 94005 |
| Party Name | INTERLINE THERAPEUTICS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Brisbane, CA 94005 |
Trademark Events
| Event Date | Event Description |
| Friday, June 2, 2023 | NEW APPLICATION ENTERED |
| Thursday, June 29, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 21, 2024 | ASSIGNED TO EXAMINER |
| Friday, February 23, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 2, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 4, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, January 6, 2025 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, January 6, 2025 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
